BioCentury
ARTICLE | Company News

Commonwealth Laboratories sales and marketing update

July 13, 2015 7:00 AM UTC

Commonwealth launched its IBSchek ELISA-based blood test to diagnose irritable bowel syndrome (IBS). The laboratory-developed test (LDT) detects antibodies against cytolethal distending toxin B (CdtB...